Published 1 year ago

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

Summary by Ground News

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. The Company's fourth quarter and full year 2022 financial results will be released after market close on Thursday, March 16, 2023. Management will provide an overview of the Company's financial results.

0 Articles

All

Left

Center

Right

Benzinga

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

DUBLIN, Ireland and CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its fourth quarter and fully year 2022 financial results before the open of the …

1 year ago·New York, United States

Read Full Article

Financial Post

Largo Reports Fourth Quarter and Full Year 2022 Financial Results; Highlights Recent Strength in the Vanadium Market and Progress on its Two-Pillar Strategy as a Tier 1 Vanadium Supplier and Emerging Clean Energy Battery Producer

All dollar amounts expressed are in thousands of U.S. dollars unless otherwise indicated.

1 year ago·Canada

Read Full Article

PR Newswire

BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023

/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies...

1 year ago·United States

Read Full Article

Globe Newswire

Alta Equipment Group Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Adjusted EBITDA Guidance for 2023

Fourth Quarter Financial Highlights: (comparisons are year over year) Total revenues increased 20.3% year over year to $428.6 millionConstruction and...

1 year ago

Read Full Article

Market Wire News

AYRWF - Ayr Wellness Reports Fourth Quarter and Full Year 2022 Results

MIAMI March 09 2023 (GLOBE NEWSWIRE) -- Ayr Wellness Inc . (CSE: AYR.A OTCQX: AYRWF) (“Ayr” or the “Company”) a.

1 year ago·United States

Read Full Article

MyChesCo

Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced its financial and operating results for the fourth quarter and full year of 2022. Fourth Quarter 2022 Highlights Fourth quarter …

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right1Center3Last Updated1 year agoBias Distribution

75% Center

Bias Distribution

75% of the sources are Center

75% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

0 Articles

0 Articles

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Iterum Therapeutics (NASDAQ:ITRM)

Largo Reports Fourth Quarter and Full Year 2022 Financial Results; Highlights Recent Strength in the Vanadium Market and Progress on its Two-Pillar Strategy as a Tier 1 Vanadium Supplier and Emerging Clean Energy Battery Producer

Largo Reports Fourth Quarter and Full Year 2022 Financial Results; Highlights Recent Strength in the Vanadium Market and Progress on its Two-Pillar Strategy as a Tier 1 Vanadium Supplier and Emerging Clean Energy Battery Producer

BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023

BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023

Alta Equipment Group Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Adjusted EBITDA Guidance for 2023

Alta Equipment Group Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Adjusted EBITDA Guidance for 2023

AYRWF - Ayr Wellness Reports Fourth Quarter and Full Year 2022 Results

AYRWF - Ayr Wellness Reports Fourth Quarter and Full Year 2022 Results

Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results

Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics